Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Rabbit Anti-PTK2B monoclonal antibody, clone TD17-26


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PTPN1 monoclonal antibody, clone KK1046


Creative Diagnostics logo
View Antibody details

Rabbit Anti-PTPN6 monoclonal antibody, clone TS52-13


Creative Diagnostics logo
View Antibody details

Rabbit Anti-Rab4A monoclonal antibody, clone TS38-19


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAB5A monoclonal antibody, clone TU58-15


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAB7A monoclonal antibody, clone TO313-14


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAB9B monoclonal antibody, clone TS56-16


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAC3 monoclonal antibody, clone KN22-30


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAD18 monoclonal antibody, clone TO77-12


Creative Diagnostics logo
View Antibody details

Rabbit Anti-RAF1 monoclonal antibody, clone TE96-18


Creative Diagnostics logo
View Antibody details